Ceftazidime–Avibactam Improves Outcomes in High-Risk Neutropenic Patients with <i>Klebsiella pneumoniae</i> Carbapenemase-Producing Enterobacterales Bacteremia

Ceftazidime–Avibactam Improves Outcomes in High-Risk Neutropenic Patients with <i>Klebsiella pneumoniae</i> Carbapenemase-Producing Enterobacterales Bacteremia

Few studies have evaluated the efficacy of ceftazidime–avibactam (CA) for <i>Klebsiella pneumoniae</i> carbapenemase-producing Enterobacterales bacteremia (KPC-PEB) in high-risk neutropenic patients. This is a prospective multicenter observational study in high-risk neutropenic patients...

Full description

Bibliographic Details
Main Authors: Fabián Herrera, Diego Torres, Ana Laborde, Rosana Jordán, Noelia Mañez, Lorena Berruezo, Sandra Lambert, Nadia Suchowiercha, Patricia Costantini, Andrea Nenna, María Laura Pereyra, José Benso, María Luz González Ibañez, María José Eusebio, Laura Barcán, Nadia Baldoni, Lucas Tula, Inés Roccia Rossi, Martín Luck, Vanesa Soto, Verónica Fernández, Alberto Ángel Carena
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Microorganisms
Subjects:
ceftazidime–avibactam
KPC-producing
bacteremia
neutropenia
Online Access:https://www.mdpi.com/2076-2607/12/1/195

Internet

https://www.mdpi.com/2076-2607/12/1/195

Similar Items